Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Intracranial application of IMRT based radiosurgery to treat multiple or large irregular lesions and verification of infra-red frameless localization system
Journal of Neuro-Oncology, 08/26/09
Lawson JD et al. – Single isocenter IMRS treatment of multiple brain metastases or large irregular lesions can be done within an acceptable treatment time and gives the benefits of dose–conformity and organ–sparing, easy plan QA, and patient setup verification.
Related Articles
Preliminary results of SIB-IMRT in head and neck cancers: Report from a regional cancer center in northern India
Journal of Cancer Research and Therapeutics, 10/27/09
Relevance Score: 88%
Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck
Annals of Oncology, 11/10/09
Relevance Score: 85%
Integral Dose in Three-dimensional Conformal Radiotherapy, Intensity-modulated Radiotherapy and Helical Tomotherapy
Clinical Oncology, 10/07/09
Relevance Score: 84%
Positional Reproducibility and Effects of a Rectal Balloon in Prostate Cancer Radiotherapy
Journal of Korean Medical Science, 10/05/09
Relevance Score: 82%
A Dosimetric Analysis Comparing Treatment of Low-Risk Prostate Cancer With TomoTherapy Versus Static Field Intensity Modulated Radiation Therapy
American Journal of Clinical Oncology, 10/07/09
Relevance Score: 80%
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
Journal of Neuro-Oncology, 12/17/09
Secretory meningiomas: A benign subgroup causing life-threatening complications
Neuro-Oncology, 12/17/09
Characterization of novel and complex genomic aberrations in glioblastoma using a 32K BAC array
Neuro-Oncology, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


